Minimal Residual Disease Assessed by Multiparameter Flow Cytometry in Multiple Myeloma: Impact on Outcome in the Medical Research Council Myeloma IX StudyAndy C. Rawstron, Roger G. Owen, Alexander J. Szubert et al.|Journal of Clinical Oncology|2013Cited by 419
Adjunctive rifampicin for Staphylococcus aureus bacteraemia (ARREST): a multicentre, randomised, double-blind, placebo-controlled trialGuy Thwaites, Elian Liu, Matthew Scarborough et al.|The Lancet|2017Cited by 186
Adjunctive rifampicin to reduce early mortality from Staphylococcus aureus bacteraemia: the ARREST RCTGuy Thwaites, A. Sarah Walker, Matthew Scarborough et al.|Health Technology Assessment|2018Cited by 15